Surgeon, at Andalusian Health Service, Spain.
Dr. Antonio Enrique Calvo Durán is a distinguished clinical surgeon specializing in abdominal surgery. Currently, he serves as the Chief Clinical Officer at Servicio Andaluz de Salud, a position he has held since 2009. Dr. Calvo has made significant contributions to hepatobiliary and pancreatic surgery, as well as oncology, particularly in the fields of cancer research and surgical treatments. His extensive clinical and research expertise has earned him recognition in Spain and beyond, making him a key figure in his field.
Profile
ORCID
Education
Dr. Calvo has an impressive academic background, with multiple advanced qualifications in the medical field. He holds a Master’s degree in Hepatobiliary and Pancreatic Surgery from the University of Barcelona (2022) and a series of other specialized diplomas and certifications, including in Oncological Digestive Surgery and Liver Transplantation. He also completed his Medical Degree at the Complutense University of Madrid in 1989.
Experience
With over three decades of experience, Dr. Calvo has contributed to numerous surgical projects and clinical trials. He has been an investigator in the European LiverMetSurvey for colorectal liver metastasis since 2009 and has also served as an evaluator and reviewer for several national and international surgical congresses and journals. His leadership extends to the management of complex surgical cases and clinical protocols in his current role.
Research Interests
Dr. Calvo’s research focuses on hepatobiliary pancreatic surgery, cancer treatment, and liver transplantation. He leads clinical trials on pancreatic cancer and liver metastasis, with particular interest in neoadjuvant therapies and the development of biomarkers for early detection of surgical complications. He is also involved in research projects analyzing the functionality of hepatocytes and the impact of tyrosine kinase inhibitors on cellular metabolism.
Awards
Dr. Calvo has received several prestigious awards, including the Dr. Luis Sagaz Zubelu Award in 2000 for his groundbreaking research on hereditary colon cancer. He has also been recognized for his continuous contributions to medical education and clinical innovation in abdominal surgery.
Publications
Dr. Calvo has authored numerous scientific publications, contributing to journals such as BMC Surgery and PLOS One. His research on the value of vein resection in pancreaticoduodenectomy and the comparison of laparoscopic and open right hemicolectomy techniques has been widely cited. Below are links to some of his key works:
- BMC Surgery (2019)
Title: The value of combined vein resection in pancreaticoduodenectomy for pancreatic head carcinoma: A meta-analysis
Authors: Antonio Enrique Calvo Durán, et al.
Received: April 1, 2019 | Accepted: June 24, 2019 | Published online: July 8, 2019
Link to the article
- PLOS ONE (2019)
Title: Laparoscopic versus open right hemicolectomy in colon carcinoma: A propensity score analysis of the DGAV StuDoQ|ColonCancer registry
Authors: Antonio Enrique Calvo Durán, et al.
Received: May 1, 2019 | Accepted: June 11, 2019 | Published: June 27, 2019
Link to the article
- BMC Gastroenterology (2020)
Title: Retroperitoneal laparoscopic hepatectomy of recurrent hepatocellular carcinoma: Case report and literature review
Authors: Antonio Enrique Calvo Durán, et al.
In Press.
Link to the article
Conclusion
Dr. Antonio Enrique Calvo Durán is undoubtedly a highly qualified candidate for the Best Researcher Award. His clinical expertise, groundbreaking research contributions, leadership in major funded projects, and active role in scientific societies highlight his exemplary commitment to advancing the medical field, particularly in surgical oncology. With continued focus on interdisciplinary research and global collaborations, his potential for further impact is vast. His already significant contributions make him an outstanding candidate for this prestigious award.